New ALS therapy in clinical trials—drug extends survival, reverses some neuromuscular damage in animals
About 20,000 people in the United States are living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The invariably fatal disease kills the nerve cells that control walking, eating and breathing. ...
Jul 16, 2018
0
1542